tirzepatide vs retatrutide preserving muscle Weight loss with retatrutide1, tirazepatide2, and semaglutide3 compared GLP-1 and Muscle Loss: Semaglutide,

Here's what could derail the thesis: Regulatory & Pricing Pressure Government price controls on GLP-1 drugs (Trump administration deal includes price cuts) Medicare/Medicaid coverage expansion requires discounting International pricing pressures as volumes increase Competition Intensifying Novo Nordisk fighting back with oral GLP-1 programs Amgen, Pfizer, and others entering the space Compounding pharmacies eating market share during supply shortages Operational Challenges Manufacturing constraints still limiting supply in some markets CVS formulary changes disrupted Zepbound access temporarily Volume growth partially offset by 10% lower realized prices in Q3 Valuation Risk At ~$930B market cap, expectations are sky-high Any guidance miss or pipeline disappointment will be punished severely Forward P/E of ~42 leaves little room for error Pipeline Execution Orforglipron approval timing uncertain Alzheimer's market adoption slower than hoped Clinical trial failures in crowded pipeline Smart investors acknowledge risks while staying focused on the long-term thesis

So, when picking between them, it really comes down to your preferences and what your doc recommends

This year's list updates include critical new clarifications and additions across multiple substance categories, with several prohibited compounds having been found in dietary supplements and research chemicals

For those experiencing constipation on tirzepatide (which affects approximately 12-16% of users according to clinical trial data), fiber is part of the solution, not the problem